Envestnet Asset Management »

Abcellera Biologics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $64k 14k 4.53
2023-09-30 $54k 12k 4.60

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Envestnet Asset Management

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
Capital World Investors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
Founders Fund VII Management
Federated Investors
Casdin Capital
Lazard Asset Management
Prosight Management
Guardian Capital Advisors
Two Sigma Advisers

View all funds holding Abcellera Biologics